Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Article
  • Published:

Induction of antitumor activity by immunization with fusions of dendritic and carcinoma cells

Abstract

Dendritic cells (DCs) are potent antigen-presenting cells that prime naive cytotoxic T-cells (CTLs)1. In this study, we have fused DCs with MC38 carcinoma cells. The fusion cells were positive for major histocompatibility (MHC) class I and II, costimulating molecules and intercellular cell adhesion molecule-1 (ICAM-1). The results show that the fusion cells stimulate naive T cells in the primary mixed lymphocyte reaction (MLR) and induce MC38 tumor-specific CTLs in vivo. Antibody-mediated depletion experiments demonstrate that induction of CD4+ and CD8+ CTLs protects against challenge with tumor cells. We also show that immunization with the fusion cells induces rejection of established metastases. These findings represent the first demonstration that fusions of DCs and tumor cells can be used in the treatment of cancer.

This is a preview of subscription content, access via your institution

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  1. Steinman, R.M. The dendritic Cell system and its role in immunogenicity. Annu. Rev. Immunol. 9, 271–296 (1991).

    Article  CAS  Google Scholar 

  2. Young, J.W. & Inaba, K., Dendritic Cells as adjuvants for class I major histocompatibility complex-restricted antitumor immunity. J. Exp. Med. 183, 7–11 (1996).

    Article  CAS  Google Scholar 

  3. Siddiqui, J. et al. Isolation and sequencing of a cDNA coding for the human DF3 breast carcinoma-associated antigen. Proc. Natl. Acad. Sci. USA 85, 2320–2323 (1988).

    Article  CAS  Google Scholar 

  4. Steinman, R.M. & Witmer, M.D. Lymphoid dendritic Cells are potent stimulators of the primary mixed leukocyte reaction in mice. Proc. Natl. Acad. Sci. USA 75, 5132–5136 (1978).

    Article  CAS  Google Scholar 

  5. Van Voorhis, W.C. et al. Relative efficacy of human monocytes and dendritic Cells as accessory Cells for T Cell replication. J. Exp. Med. 158, 174–191 (1983).

    Article  CAS  Google Scholar 

  6. Inaba, K., Young, J.W. & Steinman, R.M. Direct activation of CD8+ cytotoxic T lymphocytes by dendritic Cells. J. Exp. Med. 166, 182–194 (1987).

    Article  CAS  Google Scholar 

  7. Young, J.W. & Steinman, R.M. Dentritic Cells stimulate primary human cytolytic lymphocyte responses in the absence of CD4+ helper T Cells. J. Exp. Med. 171, 1315–1332 (1990).

    Article  CAS  Google Scholar 

  8. Inaba, K., Metlay, J.P., Crowley, M.T. & Steinman, R.M., Dendritic Cells pulsed with protein antigens in vitro can prime antigen-specific, MHC-restricted T Cells in situ. J. Exp. Med. 172, 631–640 (1990).

    Article  CAS  Google Scholar 

  9. Liu, L.M. & MacPherson, G.G. Antigen acquisition by dendritic Cells: Intestinal dendritic Cells acquire antigen administered orally and can prime naive T Cells in vivo. J. Exp. Med. 177, 1299–1307 (1993).

    Article  CAS  Google Scholar 

  10. Macatonia, S.E., Taylor, P.M., Knight, S.C. & Askonas, B.A. Primary stimulation by dendritic Cells induces antiviral proliferative and cytotoxic T Cell responses in vitro. J. Exp. Med. 169, 1255–1264 (1988).

    Article  Google Scholar 

  11. Mehta-Damani, A., Markowicz, S. & Engleman, E.G. Generation of antigen-specific CD8+ CTLs from naive precursors. J. Immunol. 153, 996–1003 (1994).

    CAS  PubMed  Google Scholar 

  12. Takahashi, H., Nakagawa, Y., Yokomuro, K. & Berzofsky, J.A. Induction of CD8+ cytotoxic T lymphocytes by immunization with syngeneic irradiated HIV-1 envelope derived peptide-pulsed dendritic Cells. Int. Immunol. 5, 849–857 (1993).

    Article  CAS  Google Scholar 

  13. Mayordomo, J.I. et al. Bone marrow-derived dendritic Cells pulsed with synthetic tumour peptides elicit protective and therapeutic antitumour immunity. Nature Med. 1, 1297–1302 (1995).

    Article  CAS  Google Scholar 

  14. Bakkar, A.B.H. et al. Generation of antimelanoma cytotoxic T lymphocytes from healthy donors after presentation of melanoma-associated antigen-derived epitopes by dendritic Cells in vitro. Cancer Res. 55, 5330–5334 (1995).

    Google Scholar 

  15. Flamand, V. et al. Murine dendritic Cells pulsed in vitro with tumor antigen induce tumor resistance in vivo. Eur. J. Immunol. 24, 605–610 (1994).

    Article  CAS  Google Scholar 

  16. Guo, Y. et al. Effective tumor vaccine generated by fusion of hepatoma Cells with activated B Cells. Science 263, 518–520 (1994).

    Article  CAS  Google Scholar 

  17. Romani, N. et al. Proliferating dendritic Cell progenitors in human blood. J. Exp. Med. 180, 83–93 (1994).

    Article  CAS  Google Scholar 

  18. Sallusto, F. & Lanzavecchia, A. Efficient presentation of soluble antigen by cultured human dendritic Cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin-4 and downregulated by tumor necrosis factor alpha. J. Exp. Med. 179, 1109–1118 (1994).

    Article  CAS  Google Scholar 

  19. Porgador, A. & Gilboa, E. Bone marrow-generated dendritic Cells pulsed with a class I-restricted peptide are potent inducers of cytotoxic T lymphocytes. J. Exp. Med. 182, 255–260 (1995).

    Article  CAS  Google Scholar 

  20. Inaba, K. et al. Generation of large numbers of dendritic Cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor. J. Exp. Med. 176, 1693–1702 (1992).

    Article  CAS  Google Scholar 

  21. Wexler, H. Accurate identification of experimental pulmonary metastases. J. Natl. Cancer Inst. 36, 641–643 (1966).

    Article  CAS  Google Scholar 

  22. Akagi, J. et al. Therapeutic antitumor response after immunization with an admixture of recombinant vaccinia viruses expressing a modified MUC1 gene and the murine T-Cell costimulatory molecule B7. J. Immunother. (in the press).

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Gong, J., Chen, D., Kashiwaba, M. et al. Induction of antitumor activity by immunization with fusions of dendritic and carcinoma cells. Nat Med 3, 558–561 (1997). https://doi.org/10.1038/nm0597-558

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nm0597-558

This article is cited by

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing